1. 291 Phase Ib study of selicrelumab (CD40 agonist) in combination with atezolizumab (anti-PD-L1) in patients with advanced solid tumors. (9th November 2020) Authors: Barlesi, Fabrice; Lolkema, Martijn; Rohrberg, Kristoffer Staal; Hierro, Cinta; Marabelle, Aurelien; Razak, Albiruni Abdul; Teixeira, Luis; Boni, Valentina; Miller, Wilson H; Aggarwal, Charu; Stern, Martin; Cirovic, Olivera; Cirovic, Olivera; Romagnoli, Barbara; Christen, Randolph; Dodia, Raksha; ... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SLy1 regulates T‐cell proliferation during Listeria monocytogenes infection in a Foxo1‐dependent manner. Issue 11 (21st September 2015) Authors: Schäll, Daniel; Schmitt, Fee; Reis, Bernhard; Brandt, Simone; Beer‐Hammer, Sandra Journal: European journal of immunology Issue: Volume 45:Issue 11(2015:Nov.) Page Start: 3087 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗